An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on 21 June 2011 |
| Author/s |
author: Ankur Singh |
| Publication date | June 21, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |